- Net sales reached $874.5M (+8.7% YoY, organic growth +11.9%)
- Adjusted diluted EPS rose 35.7% to $2.66
- Full-year guidance for net sales and adjusted EPS raised
?? Positive AI Sentiment (+6.8 / 10)
Ticker archive · $WST
$WST Filing Signals & Market Reactions
Delayed, SEO-crawlable recaps of AI-scored catalysts for $WST — including observed post-filing price moves. Live streaming stays exclusive to VIP.
? Neutral AI Sentiment (+0.5 / 10)
- West Pharmaceutical filed an 8-K under Items 1.01, 1.02, and 2.03 detailing a revised credit facility.
- The agreement covers SOFR/EUR-based revolving credit and term loans with standard margin grids.
- Routine liquidity and debt refinancing with neutral immediate financial impact.